Bariatric News: vBloc Neurometabolic Therapy
October 26, 2015 · 0 commentsvBloc Neurometabolic Therapy is the first obesity medical device to be approved by the FDA in 2015. It offers a different approach to weight loss compared to other approved devices or surgical options for adult patients with a Body Mass Index (BMI) of 40 to 45 kg/m2 or a BMI